Review



castanospermine  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress castanospermine
    Suppression of host N-glycosylation diminishes the infectivity of SARS-CoV-2. ( A ) Schematic diagram of the SARS-CoV-2 spike (S) glycoprotein. N-linked glycosylation sites are depicted as branched structures. The following protein domains are labeled: the N-terminal domain (NTD), receptor binding domain (RBD), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2), central helix (CH), transmembrane domain (TM), and C-terminal domain (CTD). ( B–D ) Infectivity of SARS-CoV-2 pseudoviruses. SARS-CoV-2 pseudoviruses were produced in HEK293T cells treated with 1 mM NB-DNJ, 1 mM <t>castanospermine,</t> or 1 μg/mL tunicamycin. The viruses were then used to infect HEK293T-ACE2 ( B ), Caco-2 ( C ), and Calu-3 ( D ) cells. Luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( E and F ) Infectivity of SARS-CoV and MERS-CoV pseudoviruses. ( G ) Infectivity of SARS-CoV-2 variants of concern (VOCs) in Caco-2 cells. Pseudoviruses were produced in HEK293T cells with or without 1 mM NB-DNJ treatment. Caco-2 cells were used as targets, and luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( H ) Replication of SARS-CoV-2 △N-GFP (MOI = 0.01) in Caco-2-N cells in the presence of N-glycosylation inhibitors (1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin). GFP fluorescence was observed 24 h post-infection via fluorescence microscopy. ( I ) Quantitation of SARS-CoV-2 △N-GFP (MOI = 0.01)-infected Caco-2-N cells via flow cytometry analysis. The data represent three biological replicates. The gating of the analysis is shown in . ( J and K ) Replication of authentic SARS-CoV-2. A549-ACE2 cells were infected with SARS-CoV-2 SH01 strain (MOI = 0.01), in the presence or absence of 1 mM NB-DNJ. Cells were harvested, and viral N gene mRNA levels were determined by RT-PCR ( J ). Viral S protein cleavage was analyzed by WB ( K ). ( L ) Cell-cell fusion mediated by the SARS-CoV-2 S protein. HEK293T cells were transfected with wild-type S and GFP plasmids. Twenty-four hours post-transfection, the spike-expressing cells were cocultured with HEK293T-ACE2 cells, and the GFP fluorescence was visualized via a fluorescence microscope after 8 h of coculture. ( M ) Western blot analysis of S protein cleavage and S1 subunit shedding induced by sACE2 in wild-type spike-expressing cells. sACE2 was added 4 h before cell collection. The supernatants were subjected to S1 immunoprecipitation via anti-FLAG M2 beads, with heavy and light chains serving as loading controls for supernatant IP. ( N ) Western blot analysis was performed to assess the effects of sACE2 (with or without NB-DNJ) on WT pseudovirus packaging, S protein cleavage, and S1 subunit shedding. The cells and supernatants were collected 4 h after sACE2 addition, and virions were purified from the supernatants via ultracentrifugation ( n = 3). ( O ) Schematic diagram of the experimental design for SARS-CoV-2 infection in K18-ACE2 mouse model ( n = 5). ( P–R ) Effect of NB-DNJ treatment on SARS-CoV-2 infection in a mouse model. K18-ACE2 mice treated with PBS or NB-DNJ were infected with BA.5.2. Infectious progeny viruses in lung tissue were determined by focus-forming units (FFUs) ( P ). Total viral N gene mRNA levels in lungs were measured by RT-PCR ( Q ). Lung tissues were analyzed by H&E staining and Immunofluorescence ( R ).
    Castanospermine, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-n2022/Castanospermine/pmc13098204-247-6-25
    Average 94 stars, based on 7 article reviews
    castanospermine - by Bioz Stars, 2026-10
    94/100 stars

    Images

    1) Product Images from "Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity"

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity

    Journal: Journal of Virology

    doi: 10.1128/jvi.00270-26

    Suppression of host N-glycosylation diminishes the infectivity of SARS-CoV-2. ( A ) Schematic diagram of the SARS-CoV-2 spike (S) glycoprotein. N-linked glycosylation sites are depicted as branched structures. The following protein domains are labeled: the N-terminal domain (NTD), receptor binding domain (RBD), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2), central helix (CH), transmembrane domain (TM), and C-terminal domain (CTD). ( B–D ) Infectivity of SARS-CoV-2 pseudoviruses. SARS-CoV-2 pseudoviruses were produced in HEK293T cells treated with 1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin. The viruses were then used to infect HEK293T-ACE2 ( B ), Caco-2 ( C ), and Calu-3 ( D ) cells. Luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( E and F ) Infectivity of SARS-CoV and MERS-CoV pseudoviruses. ( G ) Infectivity of SARS-CoV-2 variants of concern (VOCs) in Caco-2 cells. Pseudoviruses were produced in HEK293T cells with or without 1 mM NB-DNJ treatment. Caco-2 cells were used as targets, and luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( H ) Replication of SARS-CoV-2 △N-GFP (MOI = 0.01) in Caco-2-N cells in the presence of N-glycosylation inhibitors (1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin). GFP fluorescence was observed 24 h post-infection via fluorescence microscopy. ( I ) Quantitation of SARS-CoV-2 △N-GFP (MOI = 0.01)-infected Caco-2-N cells via flow cytometry analysis. The data represent three biological replicates. The gating of the analysis is shown in . ( J and K ) Replication of authentic SARS-CoV-2. A549-ACE2 cells were infected with SARS-CoV-2 SH01 strain (MOI = 0.01), in the presence or absence of 1 mM NB-DNJ. Cells were harvested, and viral N gene mRNA levels were determined by RT-PCR ( J ). Viral S protein cleavage was analyzed by WB ( K ). ( L ) Cell-cell fusion mediated by the SARS-CoV-2 S protein. HEK293T cells were transfected with wild-type S and GFP plasmids. Twenty-four hours post-transfection, the spike-expressing cells were cocultured with HEK293T-ACE2 cells, and the GFP fluorescence was visualized via a fluorescence microscope after 8 h of coculture. ( M ) Western blot analysis of S protein cleavage and S1 subunit shedding induced by sACE2 in wild-type spike-expressing cells. sACE2 was added 4 h before cell collection. The supernatants were subjected to S1 immunoprecipitation via anti-FLAG M2 beads, with heavy and light chains serving as loading controls for supernatant IP. ( N ) Western blot analysis was performed to assess the effects of sACE2 (with or without NB-DNJ) on WT pseudovirus packaging, S protein cleavage, and S1 subunit shedding. The cells and supernatants were collected 4 h after sACE2 addition, and virions were purified from the supernatants via ultracentrifugation ( n = 3). ( O ) Schematic diagram of the experimental design for SARS-CoV-2 infection in K18-ACE2 mouse model ( n = 5). ( P–R ) Effect of NB-DNJ treatment on SARS-CoV-2 infection in a mouse model. K18-ACE2 mice treated with PBS or NB-DNJ were infected with BA.5.2. Infectious progeny viruses in lung tissue were determined by focus-forming units (FFUs) ( P ). Total viral N gene mRNA levels in lungs were measured by RT-PCR ( Q ). Lung tissues were analyzed by H&E staining and Immunofluorescence ( R ).
    Figure Legend Snippet: Suppression of host N-glycosylation diminishes the infectivity of SARS-CoV-2. ( A ) Schematic diagram of the SARS-CoV-2 spike (S) glycoprotein. N-linked glycosylation sites are depicted as branched structures. The following protein domains are labeled: the N-terminal domain (NTD), receptor binding domain (RBD), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2), central helix (CH), transmembrane domain (TM), and C-terminal domain (CTD). ( B–D ) Infectivity of SARS-CoV-2 pseudoviruses. SARS-CoV-2 pseudoviruses were produced in HEK293T cells treated with 1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin. The viruses were then used to infect HEK293T-ACE2 ( B ), Caco-2 ( C ), and Calu-3 ( D ) cells. Luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( E and F ) Infectivity of SARS-CoV and MERS-CoV pseudoviruses. ( G ) Infectivity of SARS-CoV-2 variants of concern (VOCs) in Caco-2 cells. Pseudoviruses were produced in HEK293T cells with or without 1 mM NB-DNJ treatment. Caco-2 cells were used as targets, and luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( H ) Replication of SARS-CoV-2 △N-GFP (MOI = 0.01) in Caco-2-N cells in the presence of N-glycosylation inhibitors (1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin). GFP fluorescence was observed 24 h post-infection via fluorescence microscopy. ( I ) Quantitation of SARS-CoV-2 △N-GFP (MOI = 0.01)-infected Caco-2-N cells via flow cytometry analysis. The data represent three biological replicates. The gating of the analysis is shown in . ( J and K ) Replication of authentic SARS-CoV-2. A549-ACE2 cells were infected with SARS-CoV-2 SH01 strain (MOI = 0.01), in the presence or absence of 1 mM NB-DNJ. Cells were harvested, and viral N gene mRNA levels were determined by RT-PCR ( J ). Viral S protein cleavage was analyzed by WB ( K ). ( L ) Cell-cell fusion mediated by the SARS-CoV-2 S protein. HEK293T cells were transfected with wild-type S and GFP plasmids. Twenty-four hours post-transfection, the spike-expressing cells were cocultured with HEK293T-ACE2 cells, and the GFP fluorescence was visualized via a fluorescence microscope after 8 h of coculture. ( M ) Western blot analysis of S protein cleavage and S1 subunit shedding induced by sACE2 in wild-type spike-expressing cells. sACE2 was added 4 h before cell collection. The supernatants were subjected to S1 immunoprecipitation via anti-FLAG M2 beads, with heavy and light chains serving as loading controls for supernatant IP. ( N ) Western blot analysis was performed to assess the effects of sACE2 (with or without NB-DNJ) on WT pseudovirus packaging, S protein cleavage, and S1 subunit shedding. The cells and supernatants were collected 4 h after sACE2 addition, and virions were purified from the supernatants via ultracentrifugation ( n = 3). ( O ) Schematic diagram of the experimental design for SARS-CoV-2 infection in K18-ACE2 mouse model ( n = 5). ( P–R ) Effect of NB-DNJ treatment on SARS-CoV-2 infection in a mouse model. K18-ACE2 mice treated with PBS or NB-DNJ were infected with BA.5.2. Infectious progeny viruses in lung tissue were determined by focus-forming units (FFUs) ( P ). Total viral N gene mRNA levels in lungs were measured by RT-PCR ( Q ). Lung tissues were analyzed by H&E staining and Immunofluorescence ( R ).

    Techniques Used: Glycoproteomics, Infection, Labeling, Binding Assay, Produced, Luciferase, Activity Assay, Fluorescence, Microscopy, Quantitation Assay, Flow Cytometry, Reverse Transcription Polymerase Chain Reaction, Transfection, Expressing, Western Blot, Immunoprecipitation, Purification, Staining, Immunofluorescence

    Related Articles

    Glycoproteomics:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Infection:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Labeling:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Binding Assay:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Produced:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Luciferase:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Activity Assay:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Fluorescence:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Microscopy:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Quantitation Assay:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Flow Cytometry:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Reverse Transcription Polymerase Chain Reaction:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Transfection:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Expressing:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Western Blot:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Immunoprecipitation:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Purification:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Staining:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.

    Immunofluorescence:

    Article Title: Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy.
    Article Snippet: When the average tumor volume reached 50 mm3, mice were grouped (three per group) and treated daily with various drugs: IR (Indirubin, 10, 20, 40 mg/kg): MedChemExpress, CAS No. : 479-41-4.

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity.
    Article Snippet: The antibodies used for immunofluores cence and flow cytometry were as follows: anti-calnexin (Proteintech, Cat# 10427-2-AP), anti-GM130 (Proteintech, Cat# 11308-1-AP), anti-Lamin B1 (Proteintech, Cat# 12987-1- AP), anti-mouse-FITC (Sigma-Aldrich, Cat# F0257), anti-rabbit-FITC (Sigma-Aldrich, Cat# F9887), anti-human-FITC (Sigma-Aldrich, Cat# F9512), anti-mouse-TRITC (Thermo Fisher Scientific, Cat# A16165), and anti-rabbit-TRITC (Proteintech, Cat# SA00007-2).

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity
    Article Snippet: The peptides TAT (N-acetylation-GRKKRRQRRRPQ-C), TAT-WDM (N-acetylation-GRKKRRQRRRPQAKEKSD-C), TAT-SDE (N-acetylation-GRKKRRQRRRPQFLMDLEGK-NH2-C), and TAT-SIM (N-acetylation-GRKKRRQRRRPQIVMVTIML-NH2) were obtained from Synpeptide Company (Nanjing, China) with greater than 95% purity.

    Article Title: Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells
    Article Snippet: NP031112 (Tideglusib): Sigma-Aldrich, #SML0339; APExBio, #B1539; MCE, #HY-14872; CAS No.: 865854-05-3.



    Similar Products

    94
    MedChemExpress castanospermine
    Suppression of host N-glycosylation diminishes the infectivity of SARS-CoV-2. ( A ) Schematic diagram of the SARS-CoV-2 spike (S) glycoprotein. N-linked glycosylation sites are depicted as branched structures. The following protein domains are labeled: the N-terminal domain (NTD), receptor binding domain (RBD), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2), central helix (CH), transmembrane domain (TM), and C-terminal domain (CTD). ( B–D ) Infectivity of SARS-CoV-2 pseudoviruses. SARS-CoV-2 pseudoviruses were produced in HEK293T cells treated with 1 mM NB-DNJ, 1 mM <t>castanospermine,</t> or 1 μg/mL tunicamycin. The viruses were then used to infect HEK293T-ACE2 ( B ), Caco-2 ( C ), and Calu-3 ( D ) cells. Luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( E and F ) Infectivity of SARS-CoV and MERS-CoV pseudoviruses. ( G ) Infectivity of SARS-CoV-2 variants of concern (VOCs) in Caco-2 cells. Pseudoviruses were produced in HEK293T cells with or without 1 mM NB-DNJ treatment. Caco-2 cells were used as targets, and luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( H ) Replication of SARS-CoV-2 △N-GFP (MOI = 0.01) in Caco-2-N cells in the presence of N-glycosylation inhibitors (1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin). GFP fluorescence was observed 24 h post-infection via fluorescence microscopy. ( I ) Quantitation of SARS-CoV-2 △N-GFP (MOI = 0.01)-infected Caco-2-N cells via flow cytometry analysis. The data represent three biological replicates. The gating of the analysis is shown in . ( J and K ) Replication of authentic SARS-CoV-2. A549-ACE2 cells were infected with SARS-CoV-2 SH01 strain (MOI = 0.01), in the presence or absence of 1 mM NB-DNJ. Cells were harvested, and viral N gene mRNA levels were determined by RT-PCR ( J ). Viral S protein cleavage was analyzed by WB ( K ). ( L ) Cell-cell fusion mediated by the SARS-CoV-2 S protein. HEK293T cells were transfected with wild-type S and GFP plasmids. Twenty-four hours post-transfection, the spike-expressing cells were cocultured with HEK293T-ACE2 cells, and the GFP fluorescence was visualized via a fluorescence microscope after 8 h of coculture. ( M ) Western blot analysis of S protein cleavage and S1 subunit shedding induced by sACE2 in wild-type spike-expressing cells. sACE2 was added 4 h before cell collection. The supernatants were subjected to S1 immunoprecipitation via anti-FLAG M2 beads, with heavy and light chains serving as loading controls for supernatant IP. ( N ) Western blot analysis was performed to assess the effects of sACE2 (with or without NB-DNJ) on WT pseudovirus packaging, S protein cleavage, and S1 subunit shedding. The cells and supernatants were collected 4 h after sACE2 addition, and virions were purified from the supernatants via ultracentrifugation ( n = 3). ( O ) Schematic diagram of the experimental design for SARS-CoV-2 infection in K18-ACE2 mouse model ( n = 5). ( P–R ) Effect of NB-DNJ treatment on SARS-CoV-2 infection in a mouse model. K18-ACE2 mice treated with PBS or NB-DNJ were infected with BA.5.2. Infectious progeny viruses in lung tissue were determined by focus-forming units (FFUs) ( P ). Total viral N gene mRNA levels in lungs were measured by RT-PCR ( Q ). Lung tissues were analyzed by H&E staining and Immunofluorescence ( R ).
    Castanospermine, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-n2022/Castanospermine/pmc13098204-247-6-25
    Average 94 stars, based on 1 article reviews
    castanospermine - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress cas no
    Suppression of host N-glycosylation diminishes the infectivity of SARS-CoV-2. ( A ) Schematic diagram of the SARS-CoV-2 spike (S) glycoprotein. N-linked glycosylation sites are depicted as branched structures. The following protein domains are labeled: the N-terminal domain (NTD), receptor binding domain (RBD), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2), central helix (CH), transmembrane domain (TM), and C-terminal domain (CTD). ( B–D ) Infectivity of SARS-CoV-2 pseudoviruses. SARS-CoV-2 pseudoviruses were produced in HEK293T cells treated with 1 mM NB-DNJ, 1 mM <t>castanospermine,</t> or 1 μg/mL tunicamycin. The viruses were then used to infect HEK293T-ACE2 ( B ), Caco-2 ( C ), and Calu-3 ( D ) cells. Luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( E and F ) Infectivity of SARS-CoV and MERS-CoV pseudoviruses. ( G ) Infectivity of SARS-CoV-2 variants of concern (VOCs) in Caco-2 cells. Pseudoviruses were produced in HEK293T cells with or without 1 mM NB-DNJ treatment. Caco-2 cells were used as targets, and luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( H ) Replication of SARS-CoV-2 △N-GFP (MOI = 0.01) in Caco-2-N cells in the presence of N-glycosylation inhibitors (1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin). GFP fluorescence was observed 24 h post-infection via fluorescence microscopy. ( I ) Quantitation of SARS-CoV-2 △N-GFP (MOI = 0.01)-infected Caco-2-N cells via flow cytometry analysis. The data represent three biological replicates. The gating of the analysis is shown in . ( J and K ) Replication of authentic SARS-CoV-2. A549-ACE2 cells were infected with SARS-CoV-2 SH01 strain (MOI = 0.01), in the presence or absence of 1 mM NB-DNJ. Cells were harvested, and viral N gene mRNA levels were determined by RT-PCR ( J ). Viral S protein cleavage was analyzed by WB ( K ). ( L ) Cell-cell fusion mediated by the SARS-CoV-2 S protein. HEK293T cells were transfected with wild-type S and GFP plasmids. Twenty-four hours post-transfection, the spike-expressing cells were cocultured with HEK293T-ACE2 cells, and the GFP fluorescence was visualized via a fluorescence microscope after 8 h of coculture. ( M ) Western blot analysis of S protein cleavage and S1 subunit shedding induced by sACE2 in wild-type spike-expressing cells. sACE2 was added 4 h before cell collection. The supernatants were subjected to S1 immunoprecipitation via anti-FLAG M2 beads, with heavy and light chains serving as loading controls for supernatant IP. ( N ) Western blot analysis was performed to assess the effects of sACE2 (with or without NB-DNJ) on WT pseudovirus packaging, S protein cleavage, and S1 subunit shedding. The cells and supernatants were collected 4 h after sACE2 addition, and virions were purified from the supernatants via ultracentrifugation ( n = 3). ( O ) Schematic diagram of the experimental design for SARS-CoV-2 infection in K18-ACE2 mouse model ( n = 5). ( P–R ) Effect of NB-DNJ treatment on SARS-CoV-2 infection in a mouse model. K18-ACE2 mice treated with PBS or NB-DNJ were infected with BA.5.2. Infectious progeny viruses in lung tissue were determined by focus-forming units (FFUs) ( P ). Total viral N gene mRNA levels in lungs were measured by RT-PCR ( Q ). Lung tissues were analyzed by H&E staining and Immunofluorescence ( R ).
    Cas No, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-n2022/Castanospermine/pm41530396-63-27-26
    Average 94 stars, based on 1 article reviews
    cas no - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress cas number
    Suppression of host N-glycosylation diminishes the infectivity of SARS-CoV-2. ( A ) Schematic diagram of the SARS-CoV-2 spike (S) glycoprotein. N-linked glycosylation sites are depicted as branched structures. The following protein domains are labeled: the N-terminal domain (NTD), receptor binding domain (RBD), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2), central helix (CH), transmembrane domain (TM), and C-terminal domain (CTD). ( B–D ) Infectivity of SARS-CoV-2 pseudoviruses. SARS-CoV-2 pseudoviruses were produced in HEK293T cells treated with 1 mM NB-DNJ, 1 mM <t>castanospermine,</t> or 1 μg/mL tunicamycin. The viruses were then used to infect HEK293T-ACE2 ( B ), Caco-2 ( C ), and Calu-3 ( D ) cells. Luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( E and F ) Infectivity of SARS-CoV and MERS-CoV pseudoviruses. ( G ) Infectivity of SARS-CoV-2 variants of concern (VOCs) in Caco-2 cells. Pseudoviruses were produced in HEK293T cells with or without 1 mM NB-DNJ treatment. Caco-2 cells were used as targets, and luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( H ) Replication of SARS-CoV-2 △N-GFP (MOI = 0.01) in Caco-2-N cells in the presence of N-glycosylation inhibitors (1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin). GFP fluorescence was observed 24 h post-infection via fluorescence microscopy. ( I ) Quantitation of SARS-CoV-2 △N-GFP (MOI = 0.01)-infected Caco-2-N cells via flow cytometry analysis. The data represent three biological replicates. The gating of the analysis is shown in . ( J and K ) Replication of authentic SARS-CoV-2. A549-ACE2 cells were infected with SARS-CoV-2 SH01 strain (MOI = 0.01), in the presence or absence of 1 mM NB-DNJ. Cells were harvested, and viral N gene mRNA levels were determined by RT-PCR ( J ). Viral S protein cleavage was analyzed by WB ( K ). ( L ) Cell-cell fusion mediated by the SARS-CoV-2 S protein. HEK293T cells were transfected with wild-type S and GFP plasmids. Twenty-four hours post-transfection, the spike-expressing cells were cocultured with HEK293T-ACE2 cells, and the GFP fluorescence was visualized via a fluorescence microscope after 8 h of coculture. ( M ) Western blot analysis of S protein cleavage and S1 subunit shedding induced by sACE2 in wild-type spike-expressing cells. sACE2 was added 4 h before cell collection. The supernatants were subjected to S1 immunoprecipitation via anti-FLAG M2 beads, with heavy and light chains serving as loading controls for supernatant IP. ( N ) Western blot analysis was performed to assess the effects of sACE2 (with or without NB-DNJ) on WT pseudovirus packaging, S protein cleavage, and S1 subunit shedding. The cells and supernatants were collected 4 h after sACE2 addition, and virions were purified from the supernatants via ultracentrifugation ( n = 3). ( O ) Schematic diagram of the experimental design for SARS-CoV-2 infection in K18-ACE2 mouse model ( n = 5). ( P–R ) Effect of NB-DNJ treatment on SARS-CoV-2 infection in a mouse model. K18-ACE2 mice treated with PBS or NB-DNJ were infected with BA.5.2. Infectious progeny viruses in lung tissue were determined by focus-forming units (FFUs) ( P ). Total viral N gene mRNA levels in lungs were measured by RT-PCR ( Q ). Lung tissues were analyzed by H&E staining and Immunofluorescence ( R ).
    Cas Number, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-n2022/Castanospermine/pmc12606210-75-24-33
    Average 94 stars, based on 1 article reviews
    cas number - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress ba chemical abstracts service cas
    Suppression of host N-glycosylation diminishes the infectivity of SARS-CoV-2. ( A ) Schematic diagram of the SARS-CoV-2 spike (S) glycoprotein. N-linked glycosylation sites are depicted as branched structures. The following protein domains are labeled: the N-terminal domain (NTD), receptor binding domain (RBD), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2), central helix (CH), transmembrane domain (TM), and C-terminal domain (CTD). ( B–D ) Infectivity of SARS-CoV-2 pseudoviruses. SARS-CoV-2 pseudoviruses were produced in HEK293T cells treated with 1 mM NB-DNJ, 1 mM <t>castanospermine,</t> or 1 μg/mL tunicamycin. The viruses were then used to infect HEK293T-ACE2 ( B ), Caco-2 ( C ), and Calu-3 ( D ) cells. Luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( E and F ) Infectivity of SARS-CoV and MERS-CoV pseudoviruses. ( G ) Infectivity of SARS-CoV-2 variants of concern (VOCs) in Caco-2 cells. Pseudoviruses were produced in HEK293T cells with or without 1 mM NB-DNJ treatment. Caco-2 cells were used as targets, and luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( H ) Replication of SARS-CoV-2 △N-GFP (MOI = 0.01) in Caco-2-N cells in the presence of N-glycosylation inhibitors (1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin). GFP fluorescence was observed 24 h post-infection via fluorescence microscopy. ( I ) Quantitation of SARS-CoV-2 △N-GFP (MOI = 0.01)-infected Caco-2-N cells via flow cytometry analysis. The data represent three biological replicates. The gating of the analysis is shown in . ( J and K ) Replication of authentic SARS-CoV-2. A549-ACE2 cells were infected with SARS-CoV-2 SH01 strain (MOI = 0.01), in the presence or absence of 1 mM NB-DNJ. Cells were harvested, and viral N gene mRNA levels were determined by RT-PCR ( J ). Viral S protein cleavage was analyzed by WB ( K ). ( L ) Cell-cell fusion mediated by the SARS-CoV-2 S protein. HEK293T cells were transfected with wild-type S and GFP plasmids. Twenty-four hours post-transfection, the spike-expressing cells were cocultured with HEK293T-ACE2 cells, and the GFP fluorescence was visualized via a fluorescence microscope after 8 h of coculture. ( M ) Western blot analysis of S protein cleavage and S1 subunit shedding induced by sACE2 in wild-type spike-expressing cells. sACE2 was added 4 h before cell collection. The supernatants were subjected to S1 immunoprecipitation via anti-FLAG M2 beads, with heavy and light chains serving as loading controls for supernatant IP. ( N ) Western blot analysis was performed to assess the effects of sACE2 (with or without NB-DNJ) on WT pseudovirus packaging, S protein cleavage, and S1 subunit shedding. The cells and supernatants were collected 4 h after sACE2 addition, and virions were purified from the supernatants via ultracentrifugation ( n = 3). ( O ) Schematic diagram of the experimental design for SARS-CoV-2 infection in K18-ACE2 mouse model ( n = 5). ( P–R ) Effect of NB-DNJ treatment on SARS-CoV-2 infection in a mouse model. K18-ACE2 mice treated with PBS or NB-DNJ were infected with BA.5.2. Infectious progeny viruses in lung tissue were determined by focus-forming units (FFUs) ( P ). Total viral N gene mRNA levels in lungs were measured by RT-PCR ( Q ). Lung tissues were analyzed by H&E staining and Immunofluorescence ( R ).
    Ba Chemical Abstracts Service Cas, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-n2022/Castanospermine/pmc12170663-48-0-10
    Average 94 stars, based on 1 article reviews
    ba chemical abstracts service cas - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    Image Search Results


    Suppression of host N-glycosylation diminishes the infectivity of SARS-CoV-2. ( A ) Schematic diagram of the SARS-CoV-2 spike (S) glycoprotein. N-linked glycosylation sites are depicted as branched structures. The following protein domains are labeled: the N-terminal domain (NTD), receptor binding domain (RBD), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2), central helix (CH), transmembrane domain (TM), and C-terminal domain (CTD). ( B–D ) Infectivity of SARS-CoV-2 pseudoviruses. SARS-CoV-2 pseudoviruses were produced in HEK293T cells treated with 1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin. The viruses were then used to infect HEK293T-ACE2 ( B ), Caco-2 ( C ), and Calu-3 ( D ) cells. Luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( E and F ) Infectivity of SARS-CoV and MERS-CoV pseudoviruses. ( G ) Infectivity of SARS-CoV-2 variants of concern (VOCs) in Caco-2 cells. Pseudoviruses were produced in HEK293T cells with or without 1 mM NB-DNJ treatment. Caco-2 cells were used as targets, and luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( H ) Replication of SARS-CoV-2 △N-GFP (MOI = 0.01) in Caco-2-N cells in the presence of N-glycosylation inhibitors (1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin). GFP fluorescence was observed 24 h post-infection via fluorescence microscopy. ( I ) Quantitation of SARS-CoV-2 △N-GFP (MOI = 0.01)-infected Caco-2-N cells via flow cytometry analysis. The data represent three biological replicates. The gating of the analysis is shown in . ( J and K ) Replication of authentic SARS-CoV-2. A549-ACE2 cells were infected with SARS-CoV-2 SH01 strain (MOI = 0.01), in the presence or absence of 1 mM NB-DNJ. Cells were harvested, and viral N gene mRNA levels were determined by RT-PCR ( J ). Viral S protein cleavage was analyzed by WB ( K ). ( L ) Cell-cell fusion mediated by the SARS-CoV-2 S protein. HEK293T cells were transfected with wild-type S and GFP plasmids. Twenty-four hours post-transfection, the spike-expressing cells were cocultured with HEK293T-ACE2 cells, and the GFP fluorescence was visualized via a fluorescence microscope after 8 h of coculture. ( M ) Western blot analysis of S protein cleavage and S1 subunit shedding induced by sACE2 in wild-type spike-expressing cells. sACE2 was added 4 h before cell collection. The supernatants were subjected to S1 immunoprecipitation via anti-FLAG M2 beads, with heavy and light chains serving as loading controls for supernatant IP. ( N ) Western blot analysis was performed to assess the effects of sACE2 (with or without NB-DNJ) on WT pseudovirus packaging, S protein cleavage, and S1 subunit shedding. The cells and supernatants were collected 4 h after sACE2 addition, and virions were purified from the supernatants via ultracentrifugation ( n = 3). ( O ) Schematic diagram of the experimental design for SARS-CoV-2 infection in K18-ACE2 mouse model ( n = 5). ( P–R ) Effect of NB-DNJ treatment on SARS-CoV-2 infection in a mouse model. K18-ACE2 mice treated with PBS or NB-DNJ were infected with BA.5.2. Infectious progeny viruses in lung tissue were determined by focus-forming units (FFUs) ( P ). Total viral N gene mRNA levels in lungs were measured by RT-PCR ( Q ). Lung tissues were analyzed by H&E staining and Immunofluorescence ( R ).

    Journal: Journal of Virology

    Article Title: Disruption of spike protein N-glycosylation induces its endoplasmic reticulum retention and attenuates SARS-CoV-2 infectivity

    doi: 10.1128/jvi.00270-26

    Figure Lengend Snippet: Suppression of host N-glycosylation diminishes the infectivity of SARS-CoV-2. ( A ) Schematic diagram of the SARS-CoV-2 spike (S) glycoprotein. N-linked glycosylation sites are depicted as branched structures. The following protein domains are labeled: the N-terminal domain (NTD), receptor binding domain (RBD), fusion peptide (FP), heptad repeat 1 (HR1), heptad repeat 2 (HR2), central helix (CH), transmembrane domain (TM), and C-terminal domain (CTD). ( B–D ) Infectivity of SARS-CoV-2 pseudoviruses. SARS-CoV-2 pseudoviruses were produced in HEK293T cells treated with 1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin. The viruses were then used to infect HEK293T-ACE2 ( B ), Caco-2 ( C ), and Calu-3 ( D ) cells. Luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( E and F ) Infectivity of SARS-CoV and MERS-CoV pseudoviruses. ( G ) Infectivity of SARS-CoV-2 variants of concern (VOCs) in Caco-2 cells. Pseudoviruses were produced in HEK293T cells with or without 1 mM NB-DNJ treatment. Caco-2 cells were used as targets, and luciferase activity was analyzed as the fold change relative to that of the WT group ( n = 3). ( H ) Replication of SARS-CoV-2 △N-GFP (MOI = 0.01) in Caco-2-N cells in the presence of N-glycosylation inhibitors (1 mM NB-DNJ, 1 mM castanospermine, or 1 μg/mL tunicamycin). GFP fluorescence was observed 24 h post-infection via fluorescence microscopy. ( I ) Quantitation of SARS-CoV-2 △N-GFP (MOI = 0.01)-infected Caco-2-N cells via flow cytometry analysis. The data represent three biological replicates. The gating of the analysis is shown in . ( J and K ) Replication of authentic SARS-CoV-2. A549-ACE2 cells were infected with SARS-CoV-2 SH01 strain (MOI = 0.01), in the presence or absence of 1 mM NB-DNJ. Cells were harvested, and viral N gene mRNA levels were determined by RT-PCR ( J ). Viral S protein cleavage was analyzed by WB ( K ). ( L ) Cell-cell fusion mediated by the SARS-CoV-2 S protein. HEK293T cells were transfected with wild-type S and GFP plasmids. Twenty-four hours post-transfection, the spike-expressing cells were cocultured with HEK293T-ACE2 cells, and the GFP fluorescence was visualized via a fluorescence microscope after 8 h of coculture. ( M ) Western blot analysis of S protein cleavage and S1 subunit shedding induced by sACE2 in wild-type spike-expressing cells. sACE2 was added 4 h before cell collection. The supernatants were subjected to S1 immunoprecipitation via anti-FLAG M2 beads, with heavy and light chains serving as loading controls for supernatant IP. ( N ) Western blot analysis was performed to assess the effects of sACE2 (with or without NB-DNJ) on WT pseudovirus packaging, S protein cleavage, and S1 subunit shedding. The cells and supernatants were collected 4 h after sACE2 addition, and virions were purified from the supernatants via ultracentrifugation ( n = 3). ( O ) Schematic diagram of the experimental design for SARS-CoV-2 infection in K18-ACE2 mouse model ( n = 5). ( P–R ) Effect of NB-DNJ treatment on SARS-CoV-2 infection in a mouse model. K18-ACE2 mice treated with PBS or NB-DNJ were infected with BA.5.2. Infectious progeny viruses in lung tissue were determined by focus-forming units (FFUs) ( P ). Total viral N gene mRNA levels in lungs were measured by RT-PCR ( Q ). Lung tissues were analyzed by H&E staining and Immunofluorescence ( R ).

    Article Snippet: Reagents, including Miglustat (NB-DNJ) (Cat# HY-17020), Castanospermine (Cat# HY-N2022), tunicamycin (Cat# HY-A0098), furin (Cat# HY- P78747 ), and Camostat mesylate (Cat# HY-13512), were purchased from MedChemExpress (MCE).

    Techniques: Glycoproteomics, Infection, Labeling, Binding Assay, Produced, Luciferase, Activity Assay, Fluorescence, Microscopy, Quantitation Assay, Flow Cytometry, Reverse Transcription Polymerase Chain Reaction, Transfection, Expressing, Western Blot, Immunoprecipitation, Purification, Staining, Immunofluorescence